AMG 811

Generic Name: AMG 811
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20060203Systemic Lupus Erythematosus (SLE)1A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects with Systemic Lupus Erythematosus
20070283Systemic Lupus Erythematosus1A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
20100011Discoid Lupus Erythematosus1A Randomized, Double-blind, Placebo-controlled, Single Dose,Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects with Discoid Lupus Erythematosus
20101147Psoriasis1A Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Moderate to Severe Psoriasis